Related Experiment Video
Updated: Apr 30, 2026

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
Ascertaining the Kawasaki Disease-Coronavirus Disease 2019 Linkage in a Japanese Administrative Claims Database
Tomoki Mizuno1,2, Jun Suzuki1,2,3,4, Shota Takahashi2
1Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Miyagi, Japan.
Insights
This study found a significant association between COVID-19 and Kawasaki Disease (KD). Individuals diagnosed with COVID-19 showed an increased risk of developing KD in the subsequent months.
Area of Science:
- Pediatrics
- Infectious Diseases
- Epidemiology
Background:
- The link between Kawasaki Disease (KD) and coronavirus disease 2019 (COVID-19) requires further investigation.
- Real-world clinical data on the association between KD and COVID-19 are limited.
Purpose of the Study:
- To investigate the association between KD and COVID-19.
- Utilize a Japanese claims database for real-world evidence.
Main Methods:
- Employed a nested case-control study matching KD cases with controls.
- Conducted a self-controlled case-series (SCCS) analysis.
- Analyzed COVID-19 exposure within 1-90 days prior to KD diagnosis and within 120 days around COVID-19 diagnosis.
Main Results:
- Nested case-control analysis revealed a significantly higher odds of prior COVID-19 exposure in KD cases (OR 7.8 for 1-30 days; OR 3.6 for 31-60 days).
- SCCS analysis showed elevated incidence rate ratios for KD following COVID-19 diagnosis (IRR 11 for Days 1-30; IRR 6.9 for Days 31-60).
Conclusions:
- COVID-19 infection is associated with an increased risk of developing Kawasaki Disease.
- Findings suggest a potential causal link or shared pathophysiology between COVID-19 and KD.
Background:
Despite the potential association between Kawasaki Disease (KD) and coronavirus disease 2019 (COVID-19), real-world clinical associations remain unclear. We aimed to investigate the association between KD and COVID-19 using a Japanese claims database.
Methods:
Using a Japanese claims database, we identified patients diagnosed with COVID-19 between January 1, 2020, and December 31, 2022 and conducted the following two analyses: a nested case-control study wherein each KD case was matched 1:4 to controls (without KD), and conditional logistic regression analyses were used to calculate odds ratios (ORs) for COVID-19 exposure in the previous 1-30, 31-60, and 61-90 days. In the self-controlled case-series (SCCS) analysis, the observation comprised the 120 days before and after COVID-19 diagnosis (Day 0). We calculated the incidence rate ratio (IRR) of three risk periods (Days 1-30, 31-60, 61-90) after Day 0 compared with the control periods.
Results:
Nested case-control analysis matched 134 cases with 536 controls. COVID-19 exposure was identified in 26.1% (35/134) of cases and 7.3% (39/536) of controls during the previous 1-30 days (adjusted OR 7.8, 95% CI 3.2-19), and in 18.7% (25/134) and 8.8% (47/536) during the previous 31-60 days (adjusted OR 3.6, 95% CI 2.0-6.5). SCCS analysis included 124 patients, revealing elevated IRRs on Days 1-30 (95% CI: 11 [6.0-20]), and 31-60 (6.9 [3.6-13]) after COVID-19 diagnosis.
Conclusion:
The present study found that COVID-19 was associated with the development of KD.
More Related Videos
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Investigation of Disease Outbreaks
Single Nucleotide Polymorphisms-SNPs
Principles of Disease Surveillance
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Infectious Diseases and Their Occurrence
Cytomegalovirus Disease